55I LLC’s Gilead Sciences GILD Stock Holding History

55I LLC’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$977K	Buy	15,829 +11,342	+253%	+$715K	0.03%	267
2022 Q2	$277K	Buy	+4,487	New	+$278K	0.01%	454

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

55I LLC's GILD Position: Q3 2022 in Review

55I LLC increased its Gilead Sciences (GILD) stake by 253% in Q3 2022, buying an estimated $715K and bringing the position to 15,829 shares worth $977K. The position accounts for 0.03% of the portfolio, ranked #267.

55I LLC first reported a position in GILD in Q2 2022 and has held it in 2 quarters since. 1,602 funds tracked by Wall St. Rank hold GILD as of Q3 2022.

55I LLC held 15,829 shares of Gilead Sciences worth $977K as of Q3 2022.
55I LLC bought 11,342 Gilead Sciences shares in Q3 2022, an estimated $715K.
Gilead Sciences made up 0.03% of 55I LLC's portfolio in Q3 2022, its #267 holding.
55I LLC first reported a position in Gilead Sciences in Q2 2022 and has held it in 2 quarters since.
1,602 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2022.

Based on 55I LLC's 13F filing for Q3 2022, filed 14 Nov 2022.